Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

Research

Independent equity research and analysis from our analyst team

​
Company search
WindowMaster: 2026 guidance points to back on track
Research6 hours ago by
Michael Friis, Philip Coombes

WindowMaster: 2026 guidance points to back on track

In connection with yesterday’s adjustments to the 2025 guidance, WindowMaster has also provided guidance for 2026. The update points to a clear inflection in profitability, supported by improving order momentum and strong operational gearing.

WindowMaster International
Bioretec: Earnings turnaround is slipping further away
Research10 hours ago by
Antti Siltanen

Bioretec: Earnings turnaround is slipping further away

Bioretec updated its strategy and financial targets for 2026-28.

Bioretec
Remedy: Forecast model updates
Research12 hours ago by
Atte Riikola

Remedy: Forecast model updates

We have corrected assumptions in our forecast model regarding Control Resonant's assumed revenue sharing ratio with Annapurna for 2027-2028.

Remedy Entertainment

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Flügger Q2'2025/26 - Profitable rebound intact despite export market restructuring
Research12/15/2025, 7:25 AM by
Philip Coombes

Flügger Q2'2025/26 - Profitable rebound intact despite export market restructuring

Flügger delivered 2.2% revenue growth in H1 2025/26 to MDKK 1,264, as strong growth in Poland (International segment (12% y/y) and Sweden (+8% y/y) offset revenue declines in Denmark and other export nations. In the Nordics, a conversion of white-label volumes to own-brand sales in Denmark lifted margins; however, Group EBIT was stable at MDKK 141 (from MDKK 140 H1 2024/25), as terminated sales to nations in Eastern Europe and other non-core export markets had a negative impact on the International segment’s EBIT result year-over-year. Despite weaker EBIT expansion than projected in H1 2025/26 the structural value drivers of margin expansion in the Nordics from improved product mix and strong, higher margin growth in Poland remain unchanged. We still see a favourable risk-reward as Flügger executes its profitable rebound, despite possible sanctions-related risks, and reiterate our “Accumulate” recommendation and slightly lower price target of DKK 360 per share.

Flügger Group
Aktia extensive report: Asset Management determines success of strategy period
Extensive researchyesterday by
Kasper Mellas

Aktia extensive report: Asset Management determines success of strategy period

Aktia's earnings have risen significantly with interest rates, and the recovery in loan demand and steady growth in Asset Management should keep profitability relatively stable in the coming years.

Aktia Pankki
Apetit: Small dent in Food Solutions’ earnings development
Research12/15/2025, 8:38 AM by
Pauli Lohi

Apetit: Small dent in Food Solutions’ earnings development

The company cited delays in harvest season production as the reason for the profit warning.

Apetit
Remedy: Release of Control Resonant marks turning point in investment story
Research12/15/2025, 9:58 AM by
Atte Riikola

Remedy: Release of Control Resonant marks turning point in investment story

The upcoming Control sequel is a critical release for Remedy's investment case, and we are confident in its success.

Remedy Entertainment
GreenMobility (One-pager): Fourth guidance upgrade highlights continued operational momentum
Research12/12/2025, 12:45 PM by
Michael Friis, Victor Skriver

GreenMobility (One-pager): Fourth guidance upgrade highlights continued operational momentum

Yesterday, GreenMobility raised its 2025 guidance for both revenue and EBITDA for the fourth time this year, driven by stronger-than-expected revenue development. We have updated our One-pager analysis with the upgraded 2025 guidance and latest price movements.

GreenMobility
Inderes Group - Strong CMD season backs clear beat in November - SEB
Research12/12/2025, 12:03 PM

Inderes Group - Strong CMD season backs clear beat in November - SEB

Inderes delivered solid monthly sales in November with sales increasing by 15% y/y. The strong growth owes to improved CMD activity. The sales beat our estimate by EUR 0.2m, which was the case also in October. Consequently, after two months of reporting in Q4 the sales run-rate is some EUR 0.4m above our current projection. Our positive read-x is also supported by the fact that Inderes has managed to win CMDs also in Sweden.

Inderes
Fondia extensive report: Number one in continuous legal services
Extensive research12/15/2025, 9:15 AM by
Juha Kinnunen

Fondia extensive report: Number one in continuous legal services

Fondia is undergoing major transitions, and its earnings turnaround  is only just beginning. However, unlike in the past, strong measures have been taken, and success in strategic projects would lead to a significant improvement in results. This also supports confidence in a change in the outcome. Despite its challenges, Fondia is the market leader in continuous legal services in Finland, in view of which its valuation is extremely low.

Fondia
Scanfil: Accelerating earnings growth starts to attract
Research12/12/2025, 7:58 AM by
Antti Viljakainen

Scanfil: Accelerating earnings growth starts to attract

However, with the valuation decrease due to the recent around 10% price drop (2026e: P/E 12x), we feel the expected return has improved and risen slightly above the required return. In our view, Scanfil also offers an attractive investment story of profitable growth in the longer term.

Scanfil
Sanoma: On the verge of accelerating earnings growth
Research12/12/2025, 11:16 AM by
Petri Gostowski

Sanoma: On the verge of accelerating earnings growth

We have reviewed our estimates following Sanoma's Capital Markets Day and updated financial targets.

Sanoma
Puuilo Q3'25: Back on board the growth story
Research12/11/2025, 10:13 AM by
Arttu Heikura

Puuilo Q3'25: Back on board the growth story

We continue to see strong long-term growth and value creation potential for the company, and the share valuation has moderated as well.

Puuilo
Norrhydro Group extensive report: Light at the end of the cylinder
Extensive research12/3/2025, 9:35 AM by
Pauli Lohi

Norrhydro Group extensive report: Light at the end of the cylinder

Our recommendation is mainly based on the earnings turnaround in the conventional cylinder business.

Norrhydro Group
United Bankers: The sales machine is still undeperforming
Research12/2/2025, 8:26 AM by
Sauli Vilén

United Bankers: The sales machine is still undeperforming

UB's sales have picked up after a subdued start to the year, but the sales engine is still underpowered. A key challenge is the company's spearhead funds, whose sales are sluggish.

United Bankers
Impero (One-pager): Improving SaaS metrics point to momentum ahead
Research12/1/2025, 1:30 PM by
Michael Friis, Victor Skriver

Impero (One-pager): Improving SaaS metrics point to momentum ahead

Following the Q3 2025 results, we have revised our investment case one-pager to reflect the latest developments, including updated peer-group perspectives from the Danish SaaS sector.

Impero
Talenom: Value will be realized upon demerger
Research12/1/2025, 9:55 AM by
Juha Kinnunen

Talenom: Value will be realized upon demerger

The stock's valuation is now extremely attractive through a sum-of-the-parts analysis but realizing this will require not only Easor's listing but also profitability improvements in international operations. Nevertheless, we believe the risk/reward ratio is very attractive. 

Talenom
eQ extensive report: Earnings turnaround approaching, eyes on new strategy
Extensive research12/2/2025, 12:00 PM by
Sauli Vilén

eQ extensive report: Earnings turnaround approaching, eyes on new strategy

eQ's recent years have been difficult, and it has suffered badly from the challenges of Real Estate funds. However, the earnings bottom is likely to be at hand, and we expect a significant earnings improvement starting next year.

eQ
KH Group: Clearer focus going forward
Research11/28/2025, 12:01 PM by
Thomas Westerholm

KH Group: Clearer focus going forward

With the transaction, KH Group completed its strategic transformation journey, and the availability of financing for its subsidiaries should improve.

KH Group
Tietoevry clearly outlined its earnings growth drivers at CMD
Research11/26/2025, 10:45 AM by
Joni Grönqvist

Tietoevry clearly outlined its earnings growth drivers at CMD

Tietoevry held a Capital Markets Day yesterday evening, where the company, in its typical fashion, thoroughly explained when and how it expects growth and profitability improvements to materialize.

Tietoevry
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.